News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
388,945 Results
Type
Article (16011)
Company Profile (116)
Press Release (372813)
Multimedia
Podcasts (50)
Webinars (9)
Section
Business (113964)
Career Advice (497)
Deals (18820)
Drug Delivery (42)
Drug Development (37012)
Employer Resources (53)
FDA (9678)
Job Trends (8197)
News (180613)
Policy (13147)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1385)
Accelerated approval (15)
Allergies (74)
Alliances (35177)
ALS (62)
Alzheimer's disease (657)
Antibody-drug conjugate (ADC) (215)
Approvals (9930)
Artificial intelligence (449)
Autoimmune disease (69)
Automation (31)
Bankruptcy (131)
Best Places to Work (7037)
BIOSECURE Act (7)
Biosimilars (32)
Biotechnology (85)
Bladder cancer (104)
Brain cancer (45)
Breast cancer (377)
Cancer (2991)
Cardiovascular disease (179)
Career advice (456)
Career pathing (11)
CAR-T (223)
CDC (8)
Cell therapy (549)
Cervical cancer (28)
Clinical research (31500)
Collaboration (1248)
Compensation (235)
Complete response letters (14)
COVID-19 (1286)
CRISPR (87)
C-suite (485)
Cystic fibrosis (77)
Data (3373)
Decentralized trials (1)
Denatured (26)
Depression (45)
Diabetes (220)
Diagnostics (5184)
Digital health (37)
Diversity (7)
Diversity, equity & inclusion (11)
Drug discovery (169)
Drug pricing (24)
Drug shortages (4)
Duchenne muscular dystrophy (103)
Earnings (41432)
Editorial (10)
Employer branding (8)
Employer resources (47)
Events (55595)
Executive appointments (559)
FDA (11457)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (8)
Funding (910)
Gene editing (173)
Generative AI (38)
Gene therapy (364)
GLP-1 (323)
Government (1420)
Grass and pollen (3)
Guidances (226)
Healthcare (10226)
HIV (26)
Huntington's disease (16)
IgA nephropathy (26)
Immunology and inflammation (74)
Immuno-oncology (25)
Indications (60)
Infectious disease (1435)
Inflammatory bowel disease (83)
Inflation Reduction Act (6)
Influenza (73)
Intellectual property (152)
Interviews (53)
IPO (8166)
IRA (12)
Job creations (1465)
Job search strategy (400)
JPM (20)
Kidney cancer (15)
Labor market (25)
Layoffs (138)
Leadership (8)
Legal (2552)
Liver cancer (61)
Longevity (6)
Lung cancer (416)
Lymphoma (248)
Machine learning (35)
Management (18)
Manufacturing (532)
MASH (40)
Medical device (11871)
Medtech (11920)
Mergers & acquisitions (11297)
Metabolic disorders (425)
Multiple sclerosis (71)
NASH (4)
Neurodegenerative disease (129)
Neuropsychiatric disorders (23)
Neuroscience (1155)
NextGen: Class of 2026 (3600)
Non-profit (1595)
Now hiring (15)
Obesity (147)
Opinion (101)
Ovarian cancer (125)
Pain (107)
Pancreatic cancer (154)
Parkinson's disease (123)
Partnered (20)
Patents (305)
Patient recruitment (264)
Peanut (31)
People (33811)
Pharmaceutical (19)
Pharmacy benefit managers (5)
Phase 1 (10885)
Phase 2 (14052)
Phase 3 (9923)
Pipeline (2834)
Policy (62)
Postmarket research (705)
Preclinical (4439)
Press Release (66)
Prostate cancer (119)
Psychedelics (7)
Radiopharmaceuticals (190)
Rare diseases (359)
Real estate (3422)
Recruiting (22)
Regulatory (11233)
Reports (21)
Research institute (1356)
Resumes & cover letters (71)
Rett syndrome (22)
RNA editing (10)
RSV (45)
Schizophrenia (36)
Series A (164)
Series B (109)
Service/supplier (6)
Sickle cell disease (37)
Special edition (2)
Spinal muscular atrophy (79)
Sponsored (22)
Startups (2533)
State (2)
Stomach cancer (7)
Supply chain (50)
Tariffs (10)
The Weekly (23)
Vaccines (512)
Venture capital (43)
Weight loss (55)
Women's health (45)
Worklife (2)
Date
Today (5)
Last 7 days (298)
Last 30 days (1193)
Last 365 days (15913)
2026 (1499)
2025 (16251)
2024 (19908)
2023 (23246)
2022 (31930)
2021 (33709)
2020 (31576)
2019 (26677)
2018 (20059)
2017 (19512)
2016 (18263)
2015 (21174)
2014 (15523)
2013 (12943)
2012 (14032)
2011 (14323)
2010 (13029)
Location
Africa (337)
Alabama (69)
Alaska (6)
Arizona (178)
Arkansas (10)
Asia (25799)
Australia (4438)
California (5716)
Canada (1735)
China (637)
Colorado (296)
Connecticut (254)
Delaware (158)
Europe (52861)
Florida (937)
Georgia (220)
Hawaii (2)
Idaho (33)
Illinois (504)
India (34)
Indiana (288)
Iowa (10)
Japan (297)
Kansas (101)
Kentucky (20)
Louisiana (18)
Maine (22)
Maryland (734)
Massachusetts (3852)
Michigan (275)
Minnesota (430)
Mississippi (4)
Missouri (99)
Montana (27)
Nebraska (15)
Nevada (52)
New Hampshire (83)
New Jersey (1769)
New Mexico (18)
New York (1572)
North Carolina (783)
North Dakota (9)
Northern California (2520)
Ohio (178)
Oklahoma (16)
Oregon (24)
Pennsylvania (1058)
Puerto Rico (19)
Rhode Island (34)
South America (529)
South Carolina (60)
South Dakota (1)
Southern California (2386)
Tennessee (103)
Texas (964)
United States (21196)
Utah (204)
Vermont (1)
Virginia (98)
Washington D.C. (19)
Washington State (515)
West Virginia (3)
Wisconsin (88)
Wyoming (1)
388,945 Results for "median technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026
January 19, 2026
·
9 min read
Press Releases
Median Technologies Appoints Didric Cederholm to Its Board of Directors
November 3, 2025
·
4 min read
Press Releases
Median Technologies Business Update Following Successful Financing
September 23, 2025
·
9 min read
Press Releases
Median Technologies to Showcase AI-Powered Software as a Medical Device eyonis® LCS for Lung Cancer Screening at the RSNA 2025 Annual Meeting
November 26, 2025
·
6 min read
Press Releases
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy
January 26, 2026
·
14 min read
Press Releases
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit
January 7, 2026
·
14 min read
Press Releases
TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
December 11, 2025
·
12 min read
Press Releases
Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS
May 14, 2025
·
6 min read
Press Releases
Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
December 8, 2025
·
21 min read
Press Releases
ANKTIVA® with BCG Demonstrates 96% Survival from Bladder Cancer at Three Years with Median Survival Not Yet Reached in BCG-Unresponsive High-Grade Papillary-Only Non-Muscle Invasive Bladder Cancer
December 17, 2025
·
11 min read
1 of 38,895
Next
